Literature DB >> 8546206

Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line.

K Hashimoto1, T Tsujimura, Y Moriyama, A Yamatodani, M Kimura, K Tohya, M Morimoto, H Kitayama, Y Kanakura, Y Kitamura.   

Abstract

Two mutations of c-kit receptor tyrosine kinase (KIT), valine-559 to glycine (G559) and aspartic acid-814 to valine (V814), resulted in its constitutive activation. To examine the transforming and differentiation-inducing potential of the mutant KIT, we used the murine interleukin-3-dependent IC-2 mast cell line as a transfectant. The IC-2 cells contained few basophilic granules and did not express KIT on the surface. The KITG559 or KITV814 gene was introduced into IC-2 cells using a retroviral vector. KITG559 and KITV814 expressed in IC-2 cells were constitutively phosphorylated on tyrosine and demonstrated kinase activity in the absence of stem cell factor, which is a ligand for KIT. IC-2 cells expressing either KITG559 or KITV814 (IC-2G559 or IC-2V814 cells) showed factor-independent growth in suspension culture and produced tumors in nude athymic mice. In addition, IC-2G559 and IC-2V814 cells showed a more mature phenotype compared with the phenotype of the original IC-2 cells, especially after transplantation into nude mice. The number of basophilic granules and the content of histamine increased remarkably. KITG559 and KITV814 also influenced the transcriptional phenotype of mouse mast cell proteases (MMCP) in IC-2 cells. The expression of MMCP-2, MMCP-4, and MMCP-6 was much greater in IC-2G559 and IC-2V814 cells than in the original IC-2 cells. The results indicated that constitutively activated KIT had not only oncogenic activity but also differentiation-inducing activity in mast cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546206      PMCID: PMC1861586     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

Review 1.  Signalling by receptor tyrosine kinases.

Authors:  W J Fantl; D E Johnson; L T Williams
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

2.  Mast cell number in the skin of heterozygotes reflects the molecular nature of c-kit mutation.

Authors:  T Tsujimura; U Koshimizu; H Katoh; K Isozaki; Y Kanakura; T Tono; S Adachi; T Kasugai; H Tei; Y Nishimune
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

3.  Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor.

Authors:  K M Zsebo; D A Williams; E N Geissler; V C Broudy; F H Martin; H L Atkins; R Y Hsu; N C Birkett; K H Okino; D C Murdock
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

4.  Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases.

Authors:  K K Eklund; N Ghildyal; K F Austen; R L Stevens
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

5.  Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.

Authors:  T Furitsu; T Tsujimura; T Tono; H Ikeda; H Kitayama; U Koshimizu; H Sugahara; J H Butterfield; L K Ashman; Y Kanayama
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

6.  Deficient differentiation of mast cells in the skin of mi/mi mice. Usefulness of in situ hybridization for evaluation of mast cell phenotype.

Authors:  T Kasugai; K Oguri; T Jippo-Kanemoto; M Morimoto; A Yamatodani; K Yoshida; Y Ebi; K Isozaki; H Tei; T Tsujimura
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

7.  IL-10 induces transcription of the gene for mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spiralis-infected mice.

Authors:  N Ghildyal; H P McNeil; S Stechschulte; K F Austen; D Silberstein; M F Gurish; L L Somerville; R L Stevens
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

8.  Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation.

Authors:  T Tsujimura; T Furitsu; M Morimoto; K Isozaki; S Nomura; Y Matsuzawa; Y Kitamura; Y Kanakura
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

9.  Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.

Authors:  H Kitayama; Y Kanakura; T Furitsu; T Tsujimura; K Oritani; H Ikeda; H Sugahara; H Mitsui; Y Kanayama; Y Kitamura
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

10.  Poor response of cultured mast cells derived from mi/mi mutant mice to nerve growth factor.

Authors:  T Jippo; H Ushio; S Hirota; H Mizuno; A Yamatodani; S Nomura; H Matsuda; Y Kitamura
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

View more
  11 in total

1.  Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT.

Authors:  Raghuveer Singh Mali; Peilin Ma; Li-Fan Zeng; Holly Martin; Baskar Ramdas; Yantao He; Emily Sims; Sarah Nabinger; Joydeep Ghosh; Namit Sharma; Veerendra Munugalavadla; Anindya Chatterjee; Shuo Li; George Sandusky; Andrew W Craig; Kevin D Bunting; Gen-Sheng Feng; Rebecca J Chan; Zhong-Yin Zhang; Reuben Kapur
Journal:  Blood       Date:  2012-07-17       Impact factor: 22.113

2.  KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells.

Authors:  Eunice Ching Chan; Yun Bai; Geethani Bandara; Olga Simakova; Erica Brittain; Linda Scott; Kimberly D Dyer; Amy D Klion; Irina Maric; Alasdair M Gilfillan; Dean D Metcalfe; Todd M Wilson
Journal:  Exp Hematol       Date:  2013-06-04       Impact factor: 3.084

3.  Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.

Authors:  Marcia L Taylor; Devinder Sehgal; Mark Raffeld; Harold Obiakor; Cem Akin; Rose G Mage; Dean D Metcalfe
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

4.  Expression of mast-cell-specific proteases in tissues of mice studied by in situ hybridization.

Authors:  T Jippo; K Tsujino; H M Kim; D K Kim; Y M Lee; Y Nawa; Y Kitamura
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

5.  Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.

Authors:  B J Longley; D D Metcalfe; M Tharp; X Wang; L Tyrrell; S Z Lu; D Heitjan; Y Ma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

6.  Genetic and pharmacologic evidence implicating the p85 alpha, but not p85 beta, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis.

Authors:  Veerendra Munugalavadla; Emily C Sims; Jovencio Borneo; Rebecca J Chan; Reuben Kapur
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

7.  Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V.

Authors:  Christian Baumgartner; Sabine Cerny-Reiterer; Karoline Sonneck; Matthias Mayerhofer; Karoline V Gleixner; Richard Fritz; Marc Kerenyi; Cedric Boudot; Fabrice Gouilleux; Jan-Wilhelm Kornfeld; Christian Sillaber; Richard Moriggl; Peter Valent
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

8.  Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene.

Authors:  Magnus Sundström; Harissios Vliagoftis; Peter Karlberg; Joseph H Butterfield; Kenneth Nilsson; Dean D Metcalfe; Gunnar Nilsson
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

9.  Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor.

Authors:  T Kunisada; S Z Lu; H Yoshida; S Nishikawa; S Nishikawa; M Mizoguchi; S Hayashi; L Tyrrell; D A Williams; X Wang; B J Longley
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

10.  Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease.

Authors:  Peilin Ma; Raghuveer Singh Mali; Holly Martin; Baskar Ramdas; Emily Sims; Reuben Kapur
Journal:  Leukemia       Date:  2012-02-02       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.